Plasma and Intracellular Concentrations in HIV-infected Patients Requiring Hemodialysis Dosed with Tenofovir Disoproxil Fumarate and Emtricitabine: TDF and FTC in HD

Benzer Materyaller

• Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96‐week results from two randomized clinical trials
  Yazar:: Hagins, D, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• 5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
  Yazar:: Lazzarin, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine
  Yazar:: Dumond, Julie B., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
  Yazar:: Cada, Dennis J., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B
  Yazar:: Cui, Guangying, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)